GUDKnight Therapeutics Inc.TSXHealth Care
C$11.61−C$0.09Down0.77%Oct 26, 2026 close
Earnings expected November 5, 2026 (in 10 days)
Quant ScoreModel-based
0/100
—^ +0 pts (90d)

—

Profitability
0
Fin. Strength
0
Valuation
0
View full analysis
MARKET CAP
C$1.14BSMALL
P/E RATIO (TTM)
—
EPS (TTM)
C$0.16+300.00% YoY
REVENUE (TTM)
C$547.30M+47.40% YoY
GROSS MARGIN
47.4%↑ vs 47.0% prior yr
RETURN ON EQUITY
1.9%Industry: -3.6%
DIVIDEND YIELD
—
52-WEEK RANGE
C$6 – C$12
C$6C$12
Revenue — QuarterlyView Financials →

TTM RevenueC$533.12M
YoY Growth+505.29%
Net Income TTMC$6.04M
About Knight Therapeutics Inc.Full Profile

Knight Therapeutics Inc. is listed on TSX under the ticker GUD.TO.

Health CareDrug Manufacturers - Specialty & GenericTSX · GUD.TO
Peer ComparisonFull Peers →
TICKERPRICE1D▲MKT CAPP/EGROSS MARGIN
GUD.TOKnight Therapeutics Inc.
C$11.61-0.77%C$1.14B—0.5%
APTX.TOApotex Health Corp.
C$32.06-2.79%C$7.33B—0.5%
CURA.TOCuraleaf Holdings, Inc.
C$11.03-3.08%C$2.92B—0.5%
CRON.TOCronos Group Inc.
C$4.69-3.10%C$1.74B—0.5%
DHT-UN.TODRI Healthcare Trust
C$18.50-0.32%C$1.02B——
WEED.TOCanopy Growth Corporation
C$0.95+1.06%C$401.87M—0.3%
ACB.TOAurora Cannabis Inc.
C$5.46-2.15%C$345.67M—0.4%
CPH.TOCipher Pharmaceuticals Inc.
C$13.39-1.90%C$339.99M—0.8%
XLY.TOAuxly Cannabis Group Inc.
C$3.34-0.30%C$338.11M—0.5%
© 2026 WallStMonk. All rights reserved. v0.19.39Not investment advice · Data as of previous market close